Dietary supplementation with vitamin E and C attenuates dexamethasone-induced glucose intolerance in rats.
Glucocorticoid excess induces marked insulin resistance and glucose intolerance. A recent study has shown that antioxidants prevent dexamethasone (DEX)-induced insulin resistance in cultured adipocytes. The purpose of this investigation was to examine the effects of dietary vitamin E and C (Vit E/C) supplementation on DEX-induced glucose intolerance in rats. We hypothesized that feeding rats a diet supplemented with Vit E/C would improve glucose tolerance and restore insulin signaling in skeletal muscle, adipose, and liver and prevent alterations in AMPK signaling in these tissues. Male Wistar rats received either a control or Vit E/C-supplemented diet (0.5 g/kg diet each of L-ascorbate and DL-all rac-alpha-tocopherol) for 9 days prior to, and during, 5 days of daily DEX treatment (subcutaneous injections 0.8 mg/g body wt). DEX treatment resulted in increases in the glucose and insulin area under the curve (AUC) during an intraperitoneal glucose tolerance test. The glucose, but not insulin, AUC was lowered with Vit E/C supplementation. Improvements in glucose tolerance occurred independent of a restoration of PKB phosphorylation in tissues of rats stimulated with an intraperitoneal injection of insulin but were associated with increases in AMPK signaling in muscle and reductions in AMPK signaling and the expression of fatty acid oxidation enzymes in liver. There were no differences in mitochondrial enzymes in triceps muscles between groups. This study is the first to report that dietary Vit E/C supplementation can partially prevent DEX-induced glucose intolerance in rats.
Department of Agriculture, Food and Nutritional Science, University of Alberta, Edmonton, Canada.
Deon B
DB
Williams
Zhongxiao
Z
Wan
Bruce C
BC
Frier
Rhonda C
RC
Bell
Catherine J
CJ
Field
David C
DC
Wright
D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000273:Adipose Tissue / Q000378:metabolism; D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D003907:Dexamethasone / Q000009:adverse effects*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005947:Glucose / Q000378:metabolism; D018149:Glucose Intolerance / Q000139:chemically induced* / Q000378:metabolism / Q000517:prevention & control*; D007328:Insulin / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008297:Male; D018482:Muscle, Skeletal / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D015398:Signal Transduction / Q000502:physiology; D014810:Vitamin E / Q000008:administration & dosage / Q000627:therapeutic use*
D007328:Insulin; D014810:Vitamin E; D003907:Dexamethasone; D055372:AMP-Activated Protein Kinases; D005947:Glucose; D001205:Ascorbic Acid